To circumvent this issue, a study investigated ACE-specific and chymase-specific Ang II generation by directly infusing ACE- and chymase-resistant peptides in a model of diabetic nephropathy (DN) using genetically obese leptin receptor-deficient (Leprdb or db/db) mice exhibiting features of human DN [65]. This evidence concerns the gene ACE and diabetic kidney disease.